2025 SPS Seattle | Isatuximab Subcutaneous by On-Body Injector vs. Isatuximab Intravenous
Overview
NA
Target Audience
Pharmacists
This material is non‑CME, no credits are available, and a certificate will not be provided upon completion.
Faculty
Jorge J. Garcia, PharmD, MS, MHA, MBA, FACCC, FACHE
Date of Release
October 5th, 2025
-1759607296943.webp&w=3840&q=75)
-1753896303755.webp&w=3840&q=75)